A number of research firms have changed their ratings and price targets for CVS Health (NYSE: CVS): 6/13/2026 – CVS Health was downgraded by Wall Street Zen from “buy” to “hold”. 6/11/2026 – CVS Health had its “overweight” rating reaffirmed by Cantor Fitzgerald. 6/8/2026 – CVS Health had its price target raised by Mizuho from […]

Several analysts have recently updated their ratings and price targets for National HealthCare (NYSEAMERICAN: NHC): 5/18/2026 – National HealthCare was upgraded by Royal Bank Of Canada to “hold”. 5/18/2026 – National HealthCare was upgraded by The Goldman Sachs Group, Inc. to “strong-buy”. 5/18/2026 – National HealthCare was upgraded by BMO Capital Markets to “hold”. 5/18/2026 […]